The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease

Abstract

Community pharmacists could contribute to CVD secondary prevention if they had frequent contacts with general practitioners and worked in pharmacies with a higher level of involvement in EPS provision. Of all influencing factors, documentation was a predictor of both EPS provision and CVD support, indicating the importance of documentation in supporting the management of chronic conditions.

An explanatory model of community pharmacists' support in the secondary prevention of cardiovascular disease

“…Univariate and multivariate analyses were used to identify pharmacy/pharmacist characteristics that predict dependent variables. 63 The dependent variables were categorized into primary and secondary variables. The primary dependent variable was the provision of CVD support.…”

“…The secondary dependent variables and documentation predicted the primary dependent variable. 63 Table 1 presents these variables. In the current study, pharmacy/ pharmacist characteristics and attitudinal items were classified as independent variables.…”

“…63 Based on the results of the current study, these key elements are likely to be in place if pharmacists believe that it is their responsibility to provide advanced clinical services in addition to traditional product supply and dispensing services.…”

“…As pharmacist-related factors with respect to CPD points and their attendance at CVD courses also contributed to the model fit, the findings imply that the provision of such an advanced clinical service requires adequate number of pharmacists working with appropriate and relevant knowledge. 63 Another pharmacy-related factor that was estimated to influence CVD care provision is pharmacy location. In this case, community pharmacies in rural areas were more likely to have a higher level of enhanced pharmacy services than their metropolitan counterparts, 63 which may reflect their greater orientation toward delivery of health care.…”

“…63 Another pharmacy-related factor that was estimated to influence CVD care provision is pharmacy location. In this case, community pharmacies in rural areas were more likely to have a higher level of enhanced pharmacy services than their metropolitan counterparts, 63 which may reflect their greater orientation toward delivery of health care. Community pharmacies in areas with limited access to other primary care services play a valuable role in providing clinical services, 11,69 including CVD secondary prevention.…”